Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GETUG V04 bladder-preservation chemoradiotherapy trial
2011-000408-17Phase 2Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in bladder cancer and transitional cell carcinoma (TCC) comparing Radiotherapy + cisplatin with Radiotherapy + cisplatin + gemcitabine (2 arms). Primary endpoint: 2-year disease-free survival. Started Apr 2011; status: completed.
02
Drugs
cisplatingemcitabine
03
Conditions
bladder cancertransitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2011-000408-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000408-17.